Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a remote approach bring clinical trials to lung cancer patients?

NCT ID NCT06486428

Knowledge-focused Sponsor: Addario Lung Cancer Medical Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study explores whether a remote, direct-to-patient approach can improve how people with small cell lung cancer (SCLC) are reached and engaged in clinical research. It involves collecting biospecimens and surveying patients about their preferences and needs regarding new therapies. The goal is to see if this decentralized method is feasible and acceptable to patients, potentially making research participation easier and more accessible.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Remote, decentralized, direct-to-patient engagement strategy
What this could lead to
If successful, this approach could make it easier for people with small cell lung cancer to join research studies from home, potentially speeding up discovery of new treatments.
What could go wrong
This is a small, early feasibility study, so results may not apply broadly. The remote format might not suit everyone, and participation rates could be lower than hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

22 people

The number who actually took part.

Started

May 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults (USA-based) with a diagnosis of extensive stage primary SCLC or tSCLC

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Men or women greater than or equal to 18 years of age at the time of consent 2. Ability to read, write and communicate in English 3. Provide voluntary consent to participate in this study, documented via a signed informed Consent Form (ICF) 4. Willing to provide clinical and medical information related to his/her cancer diagnoses to the study team as required 5. Willing to comply with the requirements of the study 6. Diagnosis of extensive stage primary SCLC or tSCLC Exclusion Criteria: 1. Known existence of an uncontrolled intercurrent illness including, but not limited to, psychiatric illness or social situations that would impair compliance with study requirements 2. Subjects who previously enrolled to this study Note: Concurrent enrollment in other clinical trials is NOT exclusionary

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Small cell lung cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung neoplasm small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Small cell lung cancer

Contacts and locations

Locations

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Alabama, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Alaska, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Arizona, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Arkansas, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, California, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Colorado, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Connecticut, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Delaware, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, District of Columbia, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Florida, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Georgia, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Hawaii, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Idaho, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Illinois, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Indiana, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Iowa, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Kansas, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Kentucky, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Louisiana, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Maine, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Maryland, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Massachusetts, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Michigan, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Minnesota, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Mississippi, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Missouri, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Montana, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Nebraska, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Nevada, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, New Hampshire, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, New Jersey, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, New Mexico, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, New York, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, North Carolina, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, North Dakota, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Ohio, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Oklahoma, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Oregon, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Pennsylvania, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Rhode Island, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, South Carolina, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, South Dakota, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Tennessee, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Texas, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Utah, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Vermont, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Virginia, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Washington, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, West Virginia, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Wisconsin, 37232, United States

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Wyoming, 37232, United States

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.